On December 14, 2012, Cyclacel Pharmaceuticals, Inc., a Delaware corporation (Nasdaq: CYCC), entered into a Common Stock Purchase Agreement (the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE